Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis

doi:10.1056/EVIDoa2400134

Meta-Analysis

. 2024 Jul;3(7):EVIDoa2400134.

doi: 10.1056/EVIDoa2400134. Epub 2024 Jun 14.

Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis

Ying Wang¹, Sameer Parpia², Long Ge³, Diane Heels-Ansdell¹, Honghao Lai³, Meisam Abdar Esfahani¹, Bei Pan⁴, Waleed Alhazzani^{1

2}, Stefan Schandelmaier^{5

6

7}, Francois Lauzier^{8

9}, Yaseen Arabi¹⁰, Jeffrey Barletta¹¹, Adam Deane¹², Simon Finfer^{13

14

15}, David Williamson^{16

17}, Salmaan Kanji^{18

19}, Morten H Møller^{20

21}, Anders Perner^{20

21}, Mette Krag^{21

22}, Paul J Young^{23

24}, Joanna C Dionne^{1

25

26}, Naomi Hammond^{27

28}, Zhikang Ye¹, Quazi Ibrahim¹, Deborah Cook^{1

29}

Affiliations

¹ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
² Department of Oncology, McMaster University, Hamilton, ON, Canada.
³ Evidence-based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
⁴ Center of Evidence-Based Medicine, School of Basic Medical Science, Lanzhou University, Lanzhou, China.
⁵ Division of Clinical Epidemiology, University Hospital and University of Basel, Basel, Switzerland.
⁶ School of Public Health, University College Cork, Cork, Ireland.
⁷ MTA-PTE Lendület "Momentum" Evidence in Medicine Research Group, Medical School, University of Pécs, Pécs, Hungary.
⁸ Population Health and Optimal Health Practice Research Unit (Trauma-Emergency-Critical Care Medicine), CHU de Québec-Université Laval Research Centre, Québec City, QC, Canada.
⁹ Department of Medicine, Department of Anesthesiology and Critical Care, Université Laval, Québec, QC, Canada.
¹⁰ Intensive Care Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
¹¹ Department of Pharmacy Practice, College of Pharmacy, Midwestern University, Glendale, AZ.
¹² Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia.
¹³ The George Institute for Global Health, Sydney, NSW, Australia.
¹⁴ University of New South Wales, Sydney, NSW, Australia.
¹⁵ School of Public Health, Imperial College London, London, UK.
¹⁶ Pharmacy Department, Université de Montréal, Montréal, QC, Canada.
¹⁷ Pharmacy Department and Research Centre, CIUSSS-NIM Hôpital du Sacré-Cœur de Montréal, Montréal, QC, Canada.
¹⁸ Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
¹⁹ Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
²⁰ Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
²¹ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
²² Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark.
²³ Medical Research Institute of New Zealand, Wellington, New Zealand.
²⁴ Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
²⁵ Divisions of Critical Care Medicine and Gastroenterology, McMaster University, Hamilton, ON, Canada.
²⁶ Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
²⁷ Critical Care Program, The George Institute for Global Health and UNSW Sydney, NSW, Australia.
²⁸ Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia.
²⁹ Department of Medicine, McMaster University, Hamilton, ON, Canada.

PMID: 38874580
DOI: 10.1056/EVIDoa2400134

Meta-Analysis

Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis

Ying Wang et al. NEJM Evid. 2024 Jul.

. 2024 Jul;3(7):EVIDoa2400134.

doi: 10.1056/EVIDoa2400134. Epub 2024 Jun 14.

Authors

Affiliations

¹ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
² Department of Oncology, McMaster University, Hamilton, ON, Canada.
³ Evidence-based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
⁴ Center of Evidence-Based Medicine, School of Basic Medical Science, Lanzhou University, Lanzhou, China.
⁵ Division of Clinical Epidemiology, University Hospital and University of Basel, Basel, Switzerland.
⁶ School of Public Health, University College Cork, Cork, Ireland.
⁷ MTA-PTE Lendület "Momentum" Evidence in Medicine Research Group, Medical School, University of Pécs, Pécs, Hungary.
⁸ Population Health and Optimal Health Practice Research Unit (Trauma-Emergency-Critical Care Medicine), CHU de Québec-Université Laval Research Centre, Québec City, QC, Canada.
⁹ Department of Medicine, Department of Anesthesiology and Critical Care, Université Laval, Québec, QC, Canada.
¹⁰ Intensive Care Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
¹¹ Department of Pharmacy Practice, College of Pharmacy, Midwestern University, Glendale, AZ.
¹² Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia.
¹³ The George Institute for Global Health, Sydney, NSW, Australia.
¹⁴ University of New South Wales, Sydney, NSW, Australia.
¹⁵ School of Public Health, Imperial College London, London, UK.
¹⁶ Pharmacy Department, Université de Montréal, Montréal, QC, Canada.
¹⁷ Pharmacy Department and Research Centre, CIUSSS-NIM Hôpital du Sacré-Cœur de Montréal, Montréal, QC, Canada.
¹⁸ Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
¹⁹ Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
²⁰ Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
²¹ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
²² Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark.
²³ Medical Research Institute of New Zealand, Wellington, New Zealand.
²⁴ Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
²⁵ Divisions of Critical Care Medicine and Gastroenterology, McMaster University, Hamilton, ON, Canada.
²⁶ Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
²⁷ Critical Care Program, The George Institute for Global Health and UNSW Sydney, NSW, Australia.
²⁸ Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia.
²⁹ Department of Medicine, McMaster University, Hamilton, ON, Canada.

PMID: 38874580
DOI: 10.1056/EVIDoa2400134

Abstract

Background: The goal of this systematic review was to examine the efficacy and safety of proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.

Methods: We included randomized trials comparing proton-pump inhibitors versus placebo or no prophylaxis in critically ill adults, performed meta-analyses, and assessed certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations approach. To explore the effect of proton-pump inhibitors on mortality based on disease severity, a subgroup analysis was conducted combining within-trial subgroup data from the two largest trials and assessed credibility using the Instrument for Assessing the Credibility of Effect Modification Analyses.

Results: Twelve trials that enrolled 9533 patients were included. Proton-pump inhibitors were associated with a reduced incidence of clinically important upper gastrointestinal bleeding (relative risk [RR], 0.51 [95% confidence interval (CI), 0.34 to 0.76]; high certainty evidence). Proton-pump inhibitors may have little or no effect on mortality (RR, 0.99 [95% CI, 0.93 to 1.05]; low certainty). Within-trial subgroup analysis with intermediate credibility suggested that the effect of proton-pump inhibitors on mortality may differ based on disease severity. Subgroup results raise the possibility that proton-pump inhibitors may decrease 90-day mortality in less severely ill patients (RR, 0.89; 95% CI, 0.80 to 0.98) and may increase mortality in more severely ill patients (RR, 1.08; 95% CI, 0.96 to 1.20]. Proton-pump inhibitors may have no effect on pneumonia and little or no effect on Clostridioides difficile infection (low certainty).

Conclusions: High certainty evidence supports the association of proton-pump inhibitors with decreased upper gastrointestinal bleeding. Proton-pump inhibitors may have little or no effect on mortality, although a decrease in mortality in less severely ill patients and an increase in mortality in more severely ill patients remain possible. (PROSPERO number CRD42023461695.).

PubMed Disclaimer

Cited by

Role of Proton Pump Inhibitor as Stress Ulcer Prophylaxis in Sick Children: A Randomized Controlled Trial.
Kavilapurapu A, Lalitha AV, Ghosh S. Kavilapurapu A, et al. Indian Pediatr. 2025 Jun;62(6):407-413. doi: 10.1007/s13312-025-00035-3. Epub 2025 Apr 11. Indian Pediatr. 2025. PMID: 40214942 Clinical Trial.
[Stress ulcer prophylaxis with proton pump inhibitors in intensive care medicine].
Kasper P, Tacke F, Michels G. Kasper P, et al. Med Klin Intensivmed Notfmed. 2024 Oct;119(7):598-599. doi: 10.1007/s00063-024-01172-6. Epub 2024 Aug 9. Med Klin Intensivmed Notfmed. 2024. PMID: 39120611 German. No abstract available.
Stress ulcer prophylaxis practice in UK critical care units: A comparison of cross-sectional surveys between 2020 and 2024.
Borthwick M, Barton G, Boxall E, Dade JP, Farrell O, Forrest R, Graham-Clarke E, Kean D, Leigh H, Mehta R, Mulherron G, Roadley-Battin R, Sapsford D, Timmins A, Warburton J, Bourne RS. Borthwick M, et al. J Intensive Care Soc. 2025 May 26:17511437251338614. doi: 10.1177/17511437251338614. Online ahead of print. J Intensive Care Soc. 2025. PMID: 40438390 Free PMC article.
Utilizing point-of-care lactate testing for rapid prediction of clinical outcomes in patients with acute gastrointestinal bleeding in the emergency department.
Cha M, Park J. Cha M, et al. Heliyon. 2024 Sep 19;10(18):e38184. doi: 10.1016/j.heliyon.2024.e38184. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39381254 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis

Affiliations

Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical